The OCMX™ is pleased to announce the listing of Blockcube® to its online portal which offers Investors and Advisors the ability to learn more about this exciting opportunity.

JERSEY CITY, NJ, November 04, 2020 /24-7PressRelease/ — Blockcube® is a transformative company that has built a novel software solution for Clinical Trials Management for life sciences/healthcare companies.

Bloqcube® is an integrated Clinical Trial Management and Financial System (CTMFS) for drug development, whose distributed-ledger and cloud based electronic-data-capture (EDC) technology gives clinical development and healthcare professionals, speedier trials and delivers real time, immutable data in a validated system.

Our Beta test suggested a decrease in time by 50% in a semi manual observational Diabetes study. In this study we ran the study in 150 patients’ homes underscoring its versatility for trials in our Pandemic environment. Our financial module C2TA has a patent pending against it.

The OCMX™ is pleased to announce the listing of Blockcube® to its online portal which offers Investors and Advisors the ability to learn more about this exciting opportunity.

The OCMX™ has spent considerable time completing its due diligence on Blockcube® and concluded that there is indeed a tremendous potential for this opportunity.

The OCMX™ noted that Blockcube® exhibits the main components of any solid opportunity, namely a solid management team, a great track record, and a number of key competitive advantages.


• Remote monitoring solution brings Clinical Trials to patients’ homes via tablet of telemedicine without losing governance
• Decentralized system consolidates previously siloed components into a single platform
• Distributed ledger technology improves data integrity and security
• Real-time patient activity with a financial module that (C2TA (patent pending)) provides a continuous view of trial


To accelerate clinical trials using disruptive innovation. Initially, focusing on rectifying site and patient inefficiencies and later developing solution vectors that impact future clinical trial strategies, interoperability, distributed ledger technologies, and supply chain management for clinical trials.

We aim to replace, semi manual processes with multiple intermediaries, integrate siloed systems, accelerate processes, data flows, and financial transactions, and using blockchains, boost data fidelity, speed and provide data on a decentralized basis.


Rama Rao is the CEO/founder of Bloqcube®. He has 27 years of experience in the pharmaceutical industry. Before Bloqcube®, he used to work at Novartis. He was global head for developmental finance for Novartis Oncology, the head of developmental finance for the US and the CFO of Novartis Pharma in Canada/Russia.

Rajan Nagarajan is the advisor of digital transformation and supply chain management at Bloqcube®. Rajan has recently retired as the SVP – Supply Chain Management at CTI Foods, LLC. He has founded and led a consulting business engaged in process transformation, digital enablement, and change integration.

Neeraj Chandra is the advisor of business strategy and start-up scaling at Bloqcube®. He is the founder and CEO of Arkit Consultants LLC, a business and strategy consulting firm focused on scaling up of early stage and high growth companies, in cloud, blockchain, AI and Internet of Things domains. Earlier, he was Vice President of Worldwide Strategy for IBM in the software group.

Dr. Prem K. Narang is the advisor for regulatory and validation at Bloqcube®. He is the ex-head of Novartis Oncology and Global Regulatory Affairs.


The OCMX™ is changing how companies generate exposure in the financial marketplace and raise funds as we know it. The OCMX™ serves both public and private companies in need of market exposure during financial raises. It does this by way of connecting the relevant companies with financial institutions all in one online transparent portal. The OCMX™ (P2P Financial Inc.) launched in September of 2009 out of Toronto but has since expanded its operations to include Quebec, Alberta, Manitoba, and British Columbia.

The OCMX™ connects investors and advisors directly with companies seeking to raise funds or gain broad market exposure. The OCMX™ provides an open venue for innovative growth companies and leading investment funds to
generate market awareness, raise funds, or connect with investors and advisors. The OCMX™ provides companies, funds, investors, and advisors instant access to its Online Portal so that they can actively source and connect with their next opportunity, advisor, investor, client, or financing partner.

Contact Us
TD Canada Trust Tower
161 Bay Street, 45th Floor
Toronto, Ontario, M5J 2S1
Tel: 1-866-209-6862
Email: [email protected]

For the original version of this press release, please visit here